Merck Reports Topline Data for Bintrafusp Alfa as Second-Line ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
DARMSTADT, Germany, March 16, 2021 /PRNewswire-AsiaNet/ -- - Not intended for US-, Canada- or UK-based mediaMerck, a leading science and technology company, today announced topline data from the Phase II INTR@PID BTC 047 study evaluating bintrafusp alfa as a monotherapy in the second-line treatment of...
Authors: LATEST ASIANET NEWS RELEASES